2؉ -ATPase belongs to the family of P-type ATPases and maintains low concentrations of intracellular Ca 2؉ . Its reaction cycle consists of four main intermediates that alternate ion binding in the transmembrane domain with phosphorylation of an aspartate residue in a cytoplasmic domain. Previous work characterized an ultrastable phosphoenzyme produced first by labeling with fluorescein isothiocyanate, then by allowing this labeled enzyme to establish a maximal Ca 2؉ gradient, and finally by removing Ca 2؉ from the solution. This phosphoenzyme is characterized by very low fluorescence and has specific enzymatic properties suggesting the existence of a high energy phosphoryl bond. To study the structural properties of this phosphoenzyme, we used cryoelectron microscopy of two-dimensional crystals formed in the presence of decavanadate and determined the structure at 8-Å resolution. To our surprise we found that at this resolution the low fluorescence phosphoenzyme had a structure similar to that of the native enzyme crystallized under equivalent conditions. We went on to use glutaraldehyde cross-linking and proteolysis for independent structural assessment and concluded that, like the unphosphorylated native enzyme, Ca 2؉ and vanadate exert a strong influence over the global structure of this low fluorescence phosphoenzyme. Based on a structural model with fluorescein isothiocyanate bound at the ATP site, we suggest that the stability as well as the low fluorescence of this phosphoenzyme is due to a fluorescein-mediated crosslink between two cytoplasmic domains that prevents hydrolysis of the aspartyl phosphate. Finally, we consider the alternative possibility that phosphate transfer to fluorescein itself could explain the properties of this low fluorescence species.
Intracellular Ca
2ϩ concentrations are maintained at low levels by a group of ATP-dependent Ca 2ϩ pumps that belong to the family of P-type ATPases (1, 2) . These pumps maintain low intracellular Ca 2ϩ concentrations as a baseline for signal transduction pathways initiated by opening a variety of Ca 2ϩ channels. There are distinct groups of Ca 2ϩ pumps, or Ca 2ϩ -ATPases, in the plasma membrane and in membranes of the sarcoplasmic/endoplasmic reticulum. The particular isoform from sarcoplasmic reticulum (SR) 1 of skeletal muscle is the most extensively studied and represents an archetype for the entire family. Biochemical studies have defined a series of reaction intermediates that couple the energy of ATP hydrolysis within the cytoplasmic domain to alternations in the affinity and accessibility of Ca 2ϩ binding sites within the membrane domain (3) . In the key step of the reaction cycle, this energy is stored by the pump as an aspartyl phosphate and is used to drive a global conformational change that simultaneously lowers the affinity of the Ca 2ϩ sites and exposes them to the luminal side of the membrane, where the Ca 2ϩ ions are exchanged with protons. In fact, the reaction cycle appears to be driven by a series of such conformational changes, which have been deduced by biochemical and spectroscopic means and, in some cases, directly visualized by electron microscopy (EM) and x-ray crystallography (4, 5) .
In its simplest form, this reaction cycle consists of four intermediates that alternate steps of ion binding/release with those of phosphorylation/dephosphorylation of an aspartate residue. This aspartate resides at the heart of the catalytic site, and its phosphorylation by ATP is a critical step in transducing chemical energy into conformational energy for Ca 2ϩ transport. As outlined in Scheme 1, binding of cytoplasmic Ca 2ϩ is followed by formation of a "high energy" phosphoenzyme, commonly denoted either EϳP[Ca 2 ] or E 1 ϳP[Ca 2 ], in which two Ca 2ϩ ions become "occluded" within the transmembrane domain, as denoted by brackets: [Ca 2 ]. A global conformational change to a low energy phosphoenzyme (E-P or E 2 -P) exposes the Ca 2ϩ sites to the luminal side of the membrane and lowers their affinity to the millimolar range; after Ca 2ϩ release and proton binding, the phosphoenzyme is hydrolyzed to complete the cycle. E 1 and E 2 are frequently used to distinguish two hypothetical conformational states of the enzyme. E 1 exists in the first half of the cycle with high affinity Ca 2ϩ sites either cytoplasmically oriented or occluded and the catalytic aspar-tate reactive toward nucleotides. E 2 exists in the second half of the cycle with the aspartate reactive toward inorganic phosphate and low affinity Ca 2ϩ sites either exposed to the lumen or occluded with bound protons. Although the E 1 /E 2 dichotomy has been shown by Jencks and others to be an oversimplification (6) , it offers a framework for discussing the observed structural changes of the enzyme. E 1 ϩ 2Ca cyt 3 E 1 (Ca 2 ) ϩ ATP 3 E 1 ϳP[Ca 2 ] ϩ ADP 3 E 2 -P(Ca 2 ) 3 E 2 -P ϩ 2Ca lum 3 E 2 ϩ P i SCHEME 1 In recent years, the structures of four main intermediates have been defined by x-ray crystallography and electron microscopy (4, 5, 7) . These structures have taught us a great deal about the conformational changes that drive the reaction cycle and about how binding of particular substrates dictates the domain interactions responsible for these conformational changes. Specifically, binding of Ca 2ϩ to transport sites induces substantial changes to the backbone of several transmembrane helices; these changes are relayed by M4 and M5 to the cytoplasmic domain containing the catalytic aspartate (P-domain), causing its inclination and thus altering its association with the other cytoplasmic domains (denoted N-and A-domains). As a result, the aspartate is accessible to ATP bound in the Ndomain, and phosphate transfer produces a chemical bridge between these two domains that indirectly induces Ca 2ϩ occlusion. Loss of ADP disrupts this bridge and allows conserved residues on the A-domain to interact with the covalently bound phosphate group in the P-domain, thus indirectly disrupting the Ca 2ϩ sites and opening the luminal gate for Ca 2ϩ release. These same residues also orient a water molecule for hydrolysis of the aspartyl phosphate, which loosens the interaction between cytoplasmic domains and leads to proton occlusion at the transport site.
Despite these tremendous insights into the mechanisms of energy coupling, questions remain about the transitions between these intermediates and about the precise physiological context of each individual structure. In particular, the crystals used for structure determination generally require surrogate substrates to lock Ca 2ϩ -ATPase into a defined conformation, and crystal contacts have the potential to influence the juxtaposition of loosely bound domains. For instance, although crystallization of the Ca 2ϩ -bound state (E 1 (Ca 2 )) simply requires high concentrations of Ca 2ϩ (8) , the crystal contacts are likely to be responsible in part for the wide spread between the N-domain and the A-domain observed in the corresponding structure. Also, the Ca 2ϩ -free state (E 2 ) was stabilized with thapsigargin (TG) (9) , which is documented to have significant effects on binding of physiological ligands like ATP (10) and phospholamban (11) , and the high energy phosphoenzyme (E 1 ϳP) was trapped with the transition state analogue AlF 4 Ϫ in the presence of ADP (12) , thus representing an analog of the phosphoenzyme prior to nucleotide release (E 1 ϳP[Ca 2 ]⅐ADP). Finally, an analog of the low energy phosphoenzyme (E 2 ϳP) was crystallized with the MgF 4 2Ϫ or the AlF 4 Ϫ ligand bound to the catalytic aspartate, again including TG (13, 14) , which may again be expected to exert a non-physiological influence over the conformation. Similarly, lower resolution studies of the low energy phosphoenzyme employed decavanadate as a crystallization agent, which bound at the interface of the three cytoplasmic domains (15) .
An alternative procedure has been described for stabilizing a phosphoenzyme derived from the high energy intermediate, and structural characterization of this phosphoenzyme therefore holds the potential to shed light on the occlusion of calcium and on other conformational changes of the phosphoenzyme (16) 2 ) ). The ability of decavanadate to produce two-dimensional crystals within these vesicles (18) offers an opportunity to study the structural properties of this phosphoenzyme and to relate it to the other structures mentioned above.
For the current study, we optimized conditions for generating long, tubular crystals of the FITC-labeled, low fluorescence phosphoenzyme, which included addition of TG and decavanadate (19, 20) , and solved its structure at 8-Å resolution by cryoelectron microscopy and helical image analysis. Unexpectedly, the resulting structure appeared to be very similar at this resolution to that previously determined for the unlabeled, unphosphorylated enzyme under analogous conditions. We then used proteolytic cleavage and glutaraldehyde cross-linking to bring other approaches to bear on the structural analysis and to study the influence of the crystallizing conditions (namely decavanadate) on the conformation adopted by this phosphoenzyme. In the absence of decavanadate, we obtained conflicting results from proteolytic cleavage with trypsin and proteinase K (PK), suggestive of a hybrid conformation, whereas in the presence of decavanadate the results were consistent with an E 2 -like conformation, as borne out by our cryoelectron microscopic structure. We conclude that, like in the unphosphorylated native enzyme, Ca 2ϩ and vanadate exert a strong influence over the global structure of the low fluorescence phosphoenzyme. Also, although FITC is likely to mediate a cross-link between N-and P-domains that serves to protect the aspartyl phosphate, this cross-link is different than that formed by ATP during phosphate transfer. Finally, we consider the alternative possibility that FITC itself could have become phosphorylated.
MATERIALS AND METHODS
SR was prepared from the white muscle of rabbit as described by Inesi and Eletr (21) or by Champeil et al. (22) . For most labeling experiments, the preparation was diluted to 2 mg/ml protein in a buffer containing 10 mM Tris-Tricine, pH 8, 0.3 M sucrose, 1 mM MgCl 2 , 10 M CaCl 2 , and 16 M FITC, and incubated at 20°C. The loss in ATPase activity, measured using a coupled enzyme assay (23) , was used to follow the time course of labeling, which was generally complete after 15 min. The stabilized, high energy phosphoenzyme was generated as previously described (18) were applied to a PD10 column pre-equilibrated with cold buffer to remove excess of radioactivity; collected fractions were centrifuged at 70,000 ϫ g for 30 min in a Beckman rotor TLA 100.3, and the resultant pellet was resuspended in crystallization buffer prior to incubation for various periods and determination of the residual phosphorylation by filtration and scintillation counting. Tryptic cleavage was carried out at 0.75 or 2 mg/ml SR and at a trypsin:SR weight ratio of 1:50 and was stopped by acid precipitation using 4% perchloric acid. Samples were then loaded onto 12% Laemmli gels for SDS-PAGE and stained with Coomassie Blue. Proteinase K cleavage was carried out at 2 mg/ml SR and with a PK/SR weight ratio of 1:67. SDS-PAGE after proteolysis arrest was performed as previously described (25) .
For the glutaraldehyde cross-linking experiments, SR vesicles (4 mg/ml) were labeled with FITC in 50 mM EPPS/tetramethylammonium hydroxide, pH 8.0, 0.3 M sucrose, 0.1 mM CaCl 2 , 2 mM MgCl 2 , and 8 nmol/mg FITC for 20 min at room temperature. The suspension was then adjusted to pH 7.5 with a small aliquot of concentrated maleic acid and placed on ice. Formation of the low fluorescence species was performed at room temperature in 50 mM MOPS/tetramethylammonium hydroxide, pH 7.5, 0.3 M sucrose, 2 mM MgCl 2 , 0.1 mM CaCl 2 , 100 mM NaCl, 2 mM AcP, and 0.4 mg/ml SR protein labeled with FITC; unlabeled vesicles were also incubated as a control. Ca 2ϩ loading was continued for 2 min, followed by addition of 5 mM EGTA to induce the low fluorescence species. Cross-linking was performed with 1 mM glutaraldehyde over 4 min in the same basic medium of 50 mM MOPS/ tetramethylammonium hydroxide, pH 7.5, 0.3 M sucrose, 2 mM MgCl 2 , and 100 mM NaCl with various additions as indicated in the legend to Fig. 4 . The reaction was stopped by the addition of 1/10 dilution of 20% SDS, 5.4 M 2-mercaptoethanol, and a trace of bromphenol blue. The solubilized samples were subjected to SDS-PAGE with 7.5% acrylamide, and the proteins were stained with Coomassie Blue.
For preparing tubular crystals, FITC-labeled SR vesicles at 0.5 mg/ml protein were treated with 10 mM AcP, 5 mM MgCl 2 , and 0.1 mM CaCl 2 at room temperature, and the phosphoenzyme formed was then stabilized by adding 5 mM EGTA followed by 10 M TG. The fluorescence signal from FITC was used to monitor the formation of the low fluorescence species. Aliquots of 1 ml were then centrifuged at 70,000 ϫ g for 30 min as above. After removing the supernatant, crystallization buffer (typically 100 l) containing 20 mM imidazole, pH 7.2, 100 mM KCl, 5 mM MgCl 2 , and 0.5 mM decavanadate was gently added to the pellet without resuspension, followed by three cycles of freezing and thawing to induce fusion of individual SR vesicles, thus producing larger tubular crystals (20) . Protein concentrations above 10 mg/ml were required for significant fusion, with optimal results coming from the much higher concentration within a gelatinous pellet. Also, sucrose proved to be a strong inhibitor of fusion, and samples were therefore washed thoroughly prior to crystallization. After freeze-thaw, the pellet was resuspended at 1 mg/ml and incubated on ice overnight. For imaging, 5 l of this sample was pipetted onto a perforated carbon film, blotted with filter paper, and quick frozen with liquid ethane. Low dose images were recorded at a magnification of ϫ50,000 and defocus of 0.8 -1.8 m with a CM200FEG electron microscope (FEI Corp., Eindhoven, Netherlands), screened by optical diffraction, and digitized at 14-m intervals with a SCAI densitometer (Intergraph Corp., Madison, AL). After selecting well ordered tubes by optical diffraction, a group with a common helical symmetry (characterized by Bessel orders of Ϫ23 and 7 for the 1,0 and 0,1 layer lines, respectively) was selected for further processing. Defocus values were determined directly from the images (26) , and, after applying 2-fold symmetry averaging, an initial three-dimensional structure was created using standard methods of helical reconstruction. This structure was used as a reference for a suite of programs designed to account for distortions along the tubes (27) . Thereafter, a new reference was generated and the distortions were refined by a single iteration of these programs (15) . Defocus values were used to correct phases and to weight amplitudes along the layer lines. These weighted data were then averaged and fully compensated for defocus effects. The final data set was filtered, by removing data points with phase deviations Ͼ65°from those expected for crystallographic 2-fold symmetry and was truncated at 7-Å resolution. This final structure was aligned with that of the unlabeled, unphosphorylated enzyme by selecting a single molecule from the crystal lattice with a Gaussian mask and then using the program suite Spider (28) .
RESULTS

Formation and Characterization of the FITC-labeled, Low
Fluorescence Phosphoenzyme-Early work revealed the formation under specific conditions of a species of FITC-labeled Ca 2ϩ -ATPase with very low fluorescence (29) , and, more recently, this species was shown by kinetic analysis to derive from the high energy phosphoenzyme after dissociation of the Ca 2ϩ ions toward the cytosol (16) . Fig. 1A shows a typical preparation in which the fluorescence initially falls slowly as phosphoenzyme is formed during active loading of SR vesicles with AcP. Upon addition of EGTA, there is a further, precipitous reduction in fluorescence by ϳ60% to a state that is stabilized by TG. Fig.  1B shows that, if TG is added prior to EGTA, this low fluorescence species is not formed; similarly, collapse of the Ca 2ϩ gradient with Ca 2ϩ ionophore (A23187) reverses the initial fluorescence decrease induced by AcP or prevents it from forming if added prior to AcP (not shown). Fig. 1A also shows that the low fluorescence state is maintained after subsequent addition of decavanadate (18) . The fact that decavanadate actually binds to this species is documented by the slight decrease in fluorescence caused by decavanadate addition. This decrease is comparable, in relative terms, to that seen when decavanadate is added to the high fluorescence species (not shown, but see Ref. 30) , and is not simply due to absorption of the excitation wavelength by decavanadate.
We used [ 32 P]AcP to quantify the amount of covalent phosphoenzyme formed under various conditions. During active loading of SR vesicles with [
32 P]AcP, phosphoenzyme formation was complete after 4 min, reaching a maximal value of Ͼ7 nmol of phosphoenzyme/mg of protein (black circles, Fig. 1C ). In the presence of Ca 2ϩ ionophore A23187, the maximal level of phosphoenzyme was only 2 nmol/mg of protein (gray triangles), and measurements in the absence of Ca 2ϩ (gray squares) demonstrated the baseline for these measurements. Thus, the presence of a Ca 2ϩ gradient is a prerequisite for maximal phosphorylation of FITC-labeled ATPase by AcP. Furthermore, the levels reached by active loading with AcP are close to stoichiometric with the expected amount of FITC-labeled Ca 2ϩ -ATPase, and somewhat higher than those obtained with vesicles preloaded with Ca 2ϩ and phosphorylated from [ 32 P]P i (16, 18) .
Fig. 1C also shows that when EGTA was followed by TG, phosphoenzyme levels were completely stable over a 10-min period (open circles), similar to previous results with Ca 2ϩ -preloaded vesicles phosphorylated from [ 32 P]P i (18) . On the other hand, when TG was added to the phosphoenzyme prior to EGTA, thus preventing formation of the low fluorescence state (Fig. 1B) , the phosphoenzyme decayed with a half-life of 1-2 min (Fig. 1C, open triangles) . A similar decay was observed when Ca 2ϩ ionophore A23187 was added after phosphorylation ( Fig. 1C, open squares) . A comparison of fluorescence levels ( Fig. 1 , A and B) with phosphoenzyme levels (Fig. 1C ) reveals that the intermediate fluorescence species induced by AcP loading, and the low fluorescence species induced by subsequent addition of EGTA, both correspond to maximal levels of phosphoenzyme. Based on the fact that bound Ca 2ϩ could dissociate from it, the intermediate fluorescence species has been hypothesized to correspond to the normally transient enzymatic state occurring immediately prior to occlusion of Ca 2ϩ (E 1 ϳP(Ca 2 )), perhaps in rapid equilibrium with the generally more stable occluded state (E 1 ϳP[Ca 2 ]). The EGTA-induced decrease in fluorescence reflects the removal of Ca 2ϩ from the former species (16) .
To test the stability of this phosphoenzyme under conditions and time scales suitable for crystallization, we monitored 32 P retention by the FITC-labeled Ca 2ϩ -ATPase upon incubation for days at 0°C in a crystallization buffer containing EGTA, TG, and decavanadate. Fig. 1D shows that the level of phosphoenzyme, initially formed by active loading with AcP fol-
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lowed by 5 mM EGTA and 10 M TG, remained completely stable over a week in the presence of decavanadate (solid circles). The long term stability of this species, however, appeared very sensitive to the residual concentration of free Ca 2ϩ , showing slightly lower stability at 0.5 and 1.0 mM EGTA (Fig.  1D , triangles and open circles, respectively) than at 5 mM EGTA. This result is similar to the one previously found for phosphoenzyme formed from P i , which is also stable in the presence of TG and decavanadate (18) .
For optimal crystallization, we nevertheless observed that the EGTA concentration had to be lowered from 5 mM (used for producing the phosphoenzyme) to 0.5-1.0 mM. It is not clear why an elevated EGTA concentration inhibited crystallization; possibly, it was some direct effect of the polyanion on the crystallization process. In any case, crystallization appeared to be complete after overnight incubation on ice, at which time the preparations were fast frozen for electron microscopy. As indicated by our studies of phosphoenzyme stability under equivalent conditions, virtually no hydrolysis occurred over this time period (Fig. 1D) , implying that essentially all ATPase molecules remained phosphorylated under the conditions of crystallization.
Structure of the FITC-labeled Phosphoenzyme-Images of thirteen tubular crystals were selected for image processing and three-dimensional reconstruction using methods of helical image analysis (27) . These images consistently showed optical diffraction to at least 15-Å resolution. Unlike earlier work, only crystals conforming to a single helical symmetry were used for Fourier-Bessel reconstruction, allowing us to average data from all the tubes in Fourier space. Based on the 2-fold symmetry phase residual, we judged the resolution of our data to extend to 7-Å resolution (Table I) .
This reconstruction revealed that the overall shape of the FITC-labeled, phosphorylated Ca 2ϩ -ATPase ( Fig. 2A) is surprisingly similar to that previously seen for the E 2 ⅐VO 4 conformation of unlabeled, unphosphorylated Ca 2ϩ -ATPase crystallized under similar conditions either in the presence of TG (Fig.  2B ) or in its absence (31) (32) (33) . Also shown in Fig. 2C is a structure for FITC-labeled Ca 2ϩ -ATPase that was not phosphorylated prior to crystallization (15) . A noticeable hole is visible A and B) , FITC-labeled SR vesicles were suspended at 0.1 mg/ml in 2 ml of buffer consisting of 50 mM MOPS-KOH at pH 7.0, 100 mM KCl, and 5 mM MgCl 2 . For each trace, 90 M EGTA was first added, followed by 100 M Ca 2ϩ (open arrowheads), thus producing the small, but well known Ca 2ϩ -dependent FITC fluorescence changes as a calibration. Thereafter, phosphorylation was initiated by adding 10 mM AcP. A, after allowing the system to reach AcP-dependent steady-state fluorescence, the low fluorescence species (to be studied by electron microscopy) was generated by adding 2 mM EGTA, followed by 10 M TG. Subsequent addition of decavanadate did not affect the stability of the low fluorescence form, although it further reduced its fluorescence slightly. B, the low fluorescence species is not formed if 10 M TG is added prior to 2 mM EGTA. [ 32 P]AcP was then used to document the formation and stability of the low fluorescence phosphoenzyme. C, FITC-labeled SR vesicles (1 mg/ml) were incubated either in the presence (black circles) or in the absence (gray squares) of Ca 2ϩ , or in the presence of Ca 2ϩ together with the Ca 2ϩ ionophore A23187 (gray triangles), prior to the addition of 10 mM of ]AcP was eliminated using a PD10 column pre-equilibrated in AcP-free phosphorylation buffer. The collected fractions were centrifuged (40,000 rpm in a TLA 100.3 rotor for 30 min), and the pellet was resuspended at a protein concentration of 30 mg/ml in 50 mM MOPS-KOH, pH 7.0, 5 mM MgCl 2 and the stated concentrations of EGTA. After several cycles of freeze-thaw, the protein was diluted to 3 mg/ml in crystallization buffer, including TG and decavanadate, and stability of the covalent phosphoenzyme was determined at various times by filtration on Whatman filters as described under "Materials and Methods." in the cytoplasmic domain of the latter structure, which reflects the absence of decavanadate binding to this molecule (15) , as will be further discussed below. TG was used for all the structures shown in Fig. 2 , because it increases the abundance of tubular crystals present in the preparation; nevertheless, these crystals form in the absence of TG and we have previously shown that TG has no apparent effect on the disposition of the cytoplasmic domains (33) . We adopted two methods for comparing the FITC-labeled, phosphorylated Ca 2ϩ -ATPase to the non-labeled, E 2 ⅐VO 4 ⅐TG form. First, we examined the detailed fit of an atomic model for Ca 2ϩ -ATPase that was originally built for the E 2 ⅐VO 4 ⅐TG conformation (Fig. 3 , pdb code 1KJU from Ref. 15) . Using the program SITUS (34) to calculate a correlation coefficient for the fit, we found that this model fitted E 2 ⅐VO 4 ⅐TG and the present structure equally well (0.643 versus 0.649), thus precluding any significant domain displacements or significant reorganization of transmembrane helices. To look for more subtle differences between the two structures, we aligned the corresponding density maps in real space and calculated a difference map. All of the difference densities were found at the edges of the molecular envelope and probably reflect slight inaccuracies in alignment and differences in resolution between the two maps (Fig.  3A) . Although some of these differences may indicate small structural changes, e.g. a small cavity within the phosphorylation domain of the FITC-labeled phosphoenzyme that was not observed in E 2 ⅐VO 4 ⅐TG, all of these are very much smaller than the obvious movements of cytoplasmic domains and transmembrane helices that characterize comparisons of E 2 ⅐VO 4 ⅐TG, E 1 (Ca 2 ), and E 2 ⅐TG (4). In comparison, a large, obvious negative difference density is visible in the control difference map between FITC-E 2 ⅐VO 4 ⅐TG and E 2 ⅐VO 4 ⅐TG (red contours in Fig.  3B ), which results from the absence of decavanadate in the former structure (15) . A similar set of difference densities was observed in comparing FITC-E 2 ⅐VO 4 ⅐TG with FITC-EP⅐VO 4 ⅐TG (data not shown). Thus, although FITC displaces decavanadate from its intramolecular binding site on unphosphorylated Ca 2ϩ -ATPase, formation of the low fluorescence phosphoenzyme appears to reverse this effect. This difference in decavanadate binding to the phosphorylated and non-phosphorylated crystallized FITC-labeled ATPase must indicate a change in domain surfaces in this region of the molecule (see below).
Structural Insights from Glutaraldehyde Cross-linking and Proteolytic Digestion-Cross-linking the N-and P-domains of Ca 2ϩ -ATPase by glutaraldehyde has been shown to be especially sensitive to the conformation of Ca 2ϩ -ATPase. In particular, cross-linking of Lys 492 in the N-domain to Arg 678 in the P-domain is most efficient in the E 1 P conformation and occurs with lower efficiency in E 1 (Ca 2 ) and E 2 , whereas addition of either ATP or decavanadate to E 2 , or formation of E 2 -P, strongly inhibits cross-linking (35) (36) (37) . In addition to showing these effects on control, unlabeled Ca 2ϩ -ATPase samples, Fig.  4 shows results of glutaraldehyde cross-linking of FITC-labeled Ca 2ϩ -ATPase, as detected by the appearance of a band migrat- a Phase residual of final data set compared to ideal 2-fold symmetry (i.e., 0 or 180°). b Percentage of data remaining after removing data with phase error with respect to 2-fold symmetry Ͼ65°.
FIG. 2.
Three-dimensional reconstructions of the Ca 2؉ -ATPase in three different states. The structure of the low fluorescence phosphoenzyme determined in the present work (A, F-EP⅐VO 4 ⅐TG) is shown together with structures of the native enzyme (B, E 2 ⅐VO 4 ⅐TG) and of the FITC-labeled, unphosphorylated enzyme (C, F-E 2 ⅐VO 4 ⅐TG), previously presented by Xu et al. (15) . Crystallization conditions are the same in all three cases and include decavanadate and TG. Although at somewhat different resolutions (see Table I ), all three structures have the same shape, suggesting that the domains have not significantly moved as a result of FITC labeling or phosphorylation. The only obvious difference is the hole in the middle of the cytoplasmic domain in F-E 2 ⅐VO 4 ⅐TG, which results from the exclusion of decavanadate from this site in this state.
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ing at 125 kDa. In general, cross-linking is less efficient after labeling with FITC, but some general conclusions can still be drawn. Cross-linking occurs with lower efficiency for E 1 (Ca 2 ) (lanes 2 and 8) and E 2 (lanes 3 and 9). Although ATP strongly inhibits cross-linking of unlabeled Ca 2ϩ -ATPase (lane 4), ATP cannot bind to FITC-labeled Ca 2ϩ -ATPase and therefore has no effect on cross-linking (lane 10). In contrast, cross-linking of the E 1 ϳP species formed at steady-state levels by AcP was almost equally efficient with labeled and unlabeled Ca 2ϩ -ATPase (lanes 6 and 12, respectively); for FITC-labeled Ca 2ϩ -ATPase, this steady-state species corresponds to the intermediate levels of fluorescence shown in Fig. 1A . However, formation of the low fluorescent phosphoenzyme from this steady-state E 1 ϳP species produced very low cross-linking levels (lane 13), suggesting that the low fluorescence species no longer resembles E 1 ϳP, from the point of view of glutaraldehyde cross-linking.
Proteolytic cleavage is another classic method for distinguishing conformations of Ca 2ϩ -ATPase. We first considered digestion with proteinase K, which has a pair of diagnostic cleavage sites on the segments connecting M2 and M3 to the A domain (38) . The latter site (Thr 242 -E 2 43 ) represents the dominant cleavage site in the E 1 (Ca 2 ) conformation, thus producing the p83C fragment, whereas the former site (Leu 119 -Lys 120 ) is specifically cleaved in E 2 and produces the p95C fragment in addition to the p83C fragment, particularly after binding of TG ( Fig. 1 and Supplemental Material from Ref. 39 ). PK cleavage is dramatically reduced upon addition of nucleotide in the presence of Ca 2ϩ (E 1 (Ca 2 )⅐ATP), upon formation of E 1 P-like conformations, E 2 -P, or E 2 -P-like species formed with orthovanadate or decavanadate in the absence of Ca 2ϩ (E 2 ⅐decaV) (40, 41). Here, we treated FITC-labeled Ca 2ϩ -ATPase with PK after either inducing the low fluorescence phosphoenzyme (Fig.  5A, lanes 5-8) , or stabilizing the E 2 conformation (Fig. 5A,   lanes 1-4) . AcP, EGTA, and TG were added in both cases, although EGTA was added after AcP to generate the phosphoenzyme but before AcP to simply stabilize an E 2 species. The resulting proteolytic patterns were indistinguishable, with both species creating a large amount of the p95C fragment, as is characteristic of E 2 ⅐TG. We therefore conclude that even though the low fluorescence phosphoenzyme is derived from the high energy phosphoenzyme, it resembles neither a normal E 1 ϳP conformation nor an E 1 conformation, from the point of view of susceptibility to PK.
We finally turned to digestion with trypsin. Trypsin initially cleaves Ca 2ϩ -ATPase at Arg 505 to produce A and B fragments, which are not separated in our gel system, and fragment A is then cleaved at the T2 site to produce A1 and A2 subfragments. For native Ca 2ϩ -ATPase, the susceptibility of the T2 site, which is at Arg 198 on a loop not far from the conserved 181 TGES 184 motif, is most sensitive to conformation (40 -42) . E 1 (Ca 2 ) is most susceptible to cleavage at T2, whereas formation of an E 2 ⅐vanadate complex in the absence of Ca 2ϩ (using either orthovanadate or decavanadate, and presumably resembling E 2 -P) completely blocks cleavage (40) . Nucleotide binding to E 1 (Ca 2 ) or formation of the E 1 (Ca 2 )⅐AlF 4 Ϫ complex (presumably resembling E 1 ϳP[Ca 2 ]) also protects the T2 site, but to a much lesser degree (41) . Thus states analogous to E 2 -P are distinguished by their resistance to cleavage at T2 with the remaining states showing relatively subtle differences. Fig. 5B shows that the tryptic digestion patterns of FITC-labeled Ca 2ϩ -ATPase was also sensitive to the ligands present. Lanes [1] [2] [3] [4] [5] [6] show that the susceptibility of the T2 site after FITC labeling was similar to that of the native enzyme, i.e. most susceptible in the E 1 (Ca 2 ) (lane 2) and completely blocked in the presence of TG and either decavanadate or orthovanadate (lanes 5 and 6; it is however unclear whether decavanadate per se was responsible for this, or whether contaminating orthovanadate in the decavanadate solution was the active species). In the phosphorylated, low fluorescence species (lane 7), the T2 site remained highly susceptible to cleavage. However, in the presence of decavanadate (lane 8), the T2 site was blocked completely, almost as efficiently as in the non-phosphorylated E 2 -type decavanadate complex. This suggests that the low fluorescence 
species is not a rigidly defined conformation but is still influenced by the binding of certain ligands and especially by decavanadate under the conditions used for crystallization.
DISCUSSION
Previous work reported conditions for forming a stable, phosphorylated form of Ca 2ϩ -ATPase: after labeling with FITC, the enzyme is allowed to generate a steady-state Ca 2ϩ gradient by cycling with AcP and is then treated with EGTA and TG to form an ultrastable, low fluorescence phosphoenzyme (Fig. 1) . This low fluorescence phosphoenzyme is characterized by a high energy phosphoryl group in the sense that the protein is poised to transport Ca 2ϩ as soon as Ca 2ϩ binds to the cytoplasmically oriented, high affinity transport sites (16) . Furthermore, this species is distinct from E 2 -P, which either binds luminal Ca 2ϩ with low affinity or, in the absence of luminal Ca 2ϩ , is readily hydrolyzed into the unphosphorylated E 2 species. Thus, we had reasonable expectation that the FITC-labeled, low fluorescence phosphoenzyme would represent a good analogue for the E 1 ϳP conformation. In the current work, we used [
32 P] to document the stability of this phosphoenzyme under conditions of two-dimensional crystallization (Fig. 1) and reconstructed the three-dimensional structure at 8-Å resolution by cryoelectron microscopy (Fig. 2) . Although this resolution is not sufficient to reveal atomic details, it does document the juxtaposition of cytoplasmic domains and the organization of transmembrane helices. Unexpectedly, we found that the conformation of the crystallized low fluorescence phosphoenzyme was in fact indistinguishable, at this resolution, from that of the native enzyme crystallized under equivalent conditions (Fig. 3) . We then also used glutaraldehyde cross-linking and proteolysis as independent means of assessing the conformation of the low fluorescence species, and of potentially shedding light on the effect of decavanadate on its structure (Figs. 4 and  5) . These studies suggested that the low fluorescence species was a hybrid, retaining characteristics of both Ca 2ϩ -bound and Ca 2ϩ -free species, and that its conformation was sensitive to the binding of decavanadate to the cytoplasmic domains.
Conformational Effects of FITC-The very low fluorescence of the species used for crystallization has previously been attributed either to an increase in pK a of the phenolic 3-OH of fluorescein through hydrophobic/negatively charged interactions or to a salt link with basic residues surrounding the ATP pocket. Such interactions lead to a drastically stabilized aspartyl phosphate, presumably due to enhanced association of Nand P-domains (16) . In particular, intimate communication between N-and P-domains would explain the interdependence of phosphoenzyme stability (in the P-domain) and fluorescein fluorescence (in the N-domain). The ATP binding pocket from the x-ray structure of E 1 ⅐ADP⅐AlF 4 Ϫ is shown in Fig. 6A with fluorescein substituted for ADP. Arg 489 , Lys 492 , Arg 560 , and Arg 678 are all nearby and represent potential ligands to clamp the phenolic residues at the ends of the xanthenolone ring of fluorescein (43) , and stacking against the nearby Phe 487 represents another potential stabilizing element (44) . Specific interaction with these charged and/or aromatic side chains may account for fluorescent quenching after formation of E 1 P. Arg 678 is normally cross-linked to Lys 492 by glutaraldehyde, especially in E 1 P-like structures, and these residues are very close indeed in the E 1 ⅐ADP⅐AlF 4 Ϫ structure (Fig. 6A ). In the E 2 ⅐VO 4 ⅐TG structure (Fig. 6B) , the ␣-carbons for these residues have moved 13 Å further apart, which is consistent with the poor efficiency of cross-linking in E 2 P-like reaction intermediates (35) (36) (37) . According to our model, Arg 678 is within range to interact with fluorescein in both conformations, which is a likely explanation for the inhibition of glutaraldehyde crosslinking after FITC labeling and after formation of the low fluorescence phosphoenzyme (Fig. 4) . If so, FITC would be serving as a physical link between N-and P-domains, which may account for the extreme stability of the aspartyl phosphate in the low fluorescence state by perhaps altering the arrangement of catalytic residues in the phosphorylated P-domain, as well as restricting access of the A-domain to the catalytic site. Normally, phosphorylation induces a characteristic conformational change in the P-domain that allows its key residues to be gathered at the catalytic site. Additionally, the conserved 181 TGES 184 sequence in the A-domain is able to approach the catalytic site in E 2 -P and has been shown to have a critical role in orienting water for hydrolysis of the phosphoenzyme following Ca 2ϩ release to the lumen (13, 39, 45 ). More generally, structural comparison of several Ca 2ϩ -ATPase conformations indicates that the A-domain is highly mobile and undergoes trypsin (B) . A, for PK digestion, 2 mg/ml FITC-SR protein was suspended in 100 mM MOPS-NaOH, 5 mM Mg 2ϩ , and 0.1 mM Ca 2ϩ , at pH 6.5 and 20°C. For lanes 1-4, 10 mM EGTA, 0.02 mg/ml TG, and 10 mM AcP were added sequentially, resulting in a control, high fluorescence, E 2 -like state. For lanes 5-9, 10 mM AcP was added, followed first by 10 mM EGTA after 2 min, and then by 0.02 mg/ml TG, to form the stable low fluorescence phosphorylated species. Then, samples were digested with 0.03 mg/ml PK for the time intervals indicated at the top of each lane (minutes). The low fluorescence state was stable for at least 20 min after protease addition. B, for trypsin digestion, 0.75 mg/ml FITC-SR was suspended in 50 mM MOPS-NaOH, 0.1 mM Ca 2ϩ , 5 mM Mg 2ϩ , and 20% glycerol at pH 6.6 and 20°C. For lanes 3-6, 5 mM EGTA was added; 10 M TG (lane 3), 10 mM P i (lane 4), 10 M TG and 0.01 mM orthovanadate (lane 5), or 10 M TG and 1 mM decavanadate (lane 6) were also added to produce the indicated intermediates. The low fluorescence phosphoenzyme (FITC-EP, lanes 7-8) was generated by adding 10 mM AcP followed after 2 min by 5 mM EGTA, and after another 30 s by 10 M TG (lane 7) or 10 M TG and 1 mM decavanadate (lane 8). For all samples, digestion was carried out with 0.015 mg/ml trypsin (ratio of 1/50 w/w) for 1 min. Lane 9 shows molecular mass standards.
Structure of a Phosphorylated form of Ca 2ϩ -ATPase
large rotations during the binding of Ca 2ϩ to transport sites or during formation of the phosphoenzyme, thus allowing the 181 TGES 184 loop to move from a solvent-exposed position in E 1 conformations to a buried position within the catalytic pocket in E 2 -P (4, 13). Similarly, there is evidence that the N-domain is mobile in the E 1 (Ca 2 ) state (46) but becomes tethered to the P-domain during phosphate transfer from ATP, which elicits Ca 2ϩ occlusion (12, 47) . Although the FITC-labeled Ca 2ϩ -ATPase is apparently still able to undergo all these steps and transport Ca 2ϩ , the kinetics of Ca 2ϩ occlusion appear to be altered, presumably due to the formation of a long-lived reaction intermediate immediately preceding closure of the cytoplasmic gates, which could be attributed to the persistence of the N/P-domain interface at the point in the cycle when ADP would normally be released (16) . Conformational Effects of Decavanadate-Decavanadate is required for two-dimensional crystallization of all three forms of Ca 2ϩ -ATPase shown in Fig. 2 : native Ca 2ϩ -ATPase, FITClabeled unphosphorylated Ca 2ϩ -ATPase, and the low fluorescence phosphorylated species first studied here. Decavanadate has been shown to bind at two sites in the two-dimensional crystals of native Ca 2ϩ -ATPase: one site mediating intermolecular contacts at a 2-fold symmetry axis and a second intramolecular site at the interface between N-, P-, and A-domains (48) . Normally, FITC labeling completely displaces decavanadate from the intramolecular site (Fig. 2C) (15) , a result consistent with a lowered binding stoichiometry for decavanadate measured under analogous conditions (49) . Nevertheless, in the structure of the low fluorescence phosphoenzyme (FITC-EP⅐VO 4 , Fig. 2A ), density for decavanadate was clearly observed. This result must reflect some subtle alteration in the N-, P-, and A-domain interfaces upon formation of the low fluorescence state. (12, 47) . Thus, competition for these ligands could explain the competitive binding of decavanadate, ATP, and FITC to the unphosphorylated Ca 2ϩ -ATPase as shown, for example, by the displacement of TNP-AMP by decavanadate (51) .
Upon phosphorylation and formation of the low fluorescence species, these ligands and their corresponding domains appear to accommodate the binding of decavanadate, producing small but distinct fluorescence changes (Fig. 1) , reducing the accessibility of the T2 proteolytic site (Fig. 5) , and inducing crystallization. In fact, decavanadate probably further stabilizes the N-/P-domain interface. It is conceivable that in the low fluorescence phosphoenzyme, FITC no longer prevents decavanadate from binding at the intramolecular site, because specific interaction of FITC with one of the residues at this domain interface holds FITC in a favorable position. Protection of the T2 site of FITC-EP by decavanadate is consistent with rotation of the A-domain to the position seen in our new structure, which is indistinguishable from the position adopted by the unlabeled enzyme or by FITC-labeled, unphosphorylated enzyme (Figs. 2  and 3 ). Yet, the fact that the cytoplasmic domains adopt the same configuration in FITC-labeled unphosphorylated enzyme (F-E 2 ⅐VO 4 ⅐TG in Fig. 2) , despite the lack of decavanadate binding, indicates that decavanadate is not stabilizing an artificial structure. In this respect, it is also notable that the 1KJU structure, which was fitted into the EM density derived from two-dimensional crystals of E 2 ⅐VO 4 ⅐TG, does not show any significant reorganization of cytosolic domains, compared with the structure of a decavanadate-free E 2 P-like species recently derived from three-dimensional crystals of E 2 ⅐MgF 4 ⅐TG (47). Furthermore, although decavanadate does cause a small decrease . Also, the ␣-carbon for Arg 678 is 13 Å further away from Lys 492 , accounting for the low efficiency of glutaraldehyde crosslinking in E 2 P-like species. Nevertheless, the 3-O phenolic group of FITC is still within range for interaction with Arg 678 . All views represent a 17-Å-thick slab at the interface of the N-and P-domains. Insets provide an overview of the entire molecule with the N-, P-, and A-domains shown in green, magenta, and yellow, respectively; M4 and M5 are colored blue, and other transmembrane helices are white. The figure was prepared with Swiss PDB Viewer and PovRay.
in fluorescence, probably due to Förster transfer, it does not fundamentally disrupt the low fluorescence state or the chemical stability of the aspartyl phosphate (18) .
What Does Proteolysis Tell Us About the Structure?-Our tryptic digestion experiments suggest that, prior to the addition of decavanadate, the low fluorescence species has a relatively exposed T2 cleavage site, perhaps similar to E 1 . However, the pattern of PK digestion most closely resembles that of E 2 . The T2 site (Arg 198 ) is on a loop in the mobile A-domain, which is held firmly against the P-domain in E 2 ⅐VO 4 or is rotated by 90°in E 1 (Ca 2 ) and thus exposed to solvent. Similarly, the PK site (Leu-Lys 120 ) is on the link between the A-domain and transmembrane helix M2, and its susceptibility is influenced by interaction of the M2 and M3 links with the P-domain (39) . The hybrid behavior of the low fluorescence species might reflect structural flexibility arising 1) from the lack of Ca 2ϩ at the transport sites and 2) from the inability to form a true E 2 -P structure at the catalytic site. Such flexibility was previously invoked to explain the fact that E 1 (Ca 2 )⅐AMPPCP is considerably more susceptible to PK than E 1 (Ca 2 )⅐ADP⅐AlF 4 Ϫ , despite having virtually identical atomic structures; in this case, the susceptibility to PK also correlated with inability to occlude Ca 2ϩ (12) . In the case of our low fluorescence species, flexibility of its A-domain is consistent with the effectiveness of either orthovanadate or decavanadate in inhibiting tryptic cleavage at the T2 site and in stabilizing the A-domain in the position seen in our structure. PK proteolytic patterns for the low fluorescence phosphoenzyme are indistinguishable from those for the unphosphorylated enzyme in the absence of Ca 2ϩ and in the presence of TG (with or without FITC), which is consistent with the ability of vanadate to induce similar structures for all three forms (Fig. 2) . We conclude that the conformation of the low fluorescence phosphoenzyme is significantly influenced by the various ligands studied, i.e. orthovanadate or decavanadate, and of course Ca 2ϩ , as it binds to transport sites and induces the enzyme to reenter the catalytic cycle.
Ca 2ϩ Is a Dominant Determinant of Ca 2ϩ -ATPase Conformation-X-ray structures show that Ca 2ϩ has a profound effect on the transmembrane helices, causing curving of the central M5 helix and large displacements of M1, M2, M3, M4, and M6. These changes are presumably initiated by recruitment of ligands to bind the pair of Ca 2ϩ ions and relaxation of these same ligands into a significantly different configuration in the absence of Ca 2ϩ . In contrast, these structures show that the presence of ligands at the catalytic site have relatively minor effects on the structure of the membrane helices (e.g. compare E 2 ⅐TG and E 2 ⅐MgF 4 ⅐TG in Ref. 13 , and compare E 1 (Ca 2 ) and E 1 ⅐AMPPCP in Ref. 47 ). These observations are in line with the fact that TG binds only to Ca 2ϩ -free, E 2 -like species of Ca 2ϩ -ATPase (52, 53) , and the ability of TG to stabilize the FITClabeled, low fluorescence species suggests that in this species the transmembrane helices adopt an E 2 -like configuration, which is likely to be a direct result of Ca 2ϩ dissociation from the FITC-labeled E 1 P species present at steady state. Indeed, the membrane domain in our current structure of the low fluorescence phosphoenzyme is identical to that of E 2 ⅐VO 4 , at least at 6-to 7-Å resolution, and certainly distinct from the structure expected for an E 1 conformation. The lesson would seem to be that Ca 2ϩ is the primary determinant of the global conformation of Ca 2ϩ -ATPase, given its definitive influence over the entire transmembrane domain and its ability to control cytoplasmic domain associations and thus ligand binding. Obviously, the cytoplasmic domains are also able to exert some influence over the membrane domain, but this appears to be confined to relatively minor structural changes that open and close gates that control access of Ca 2ϩ to the binding sites, as well as to some as yet undefined mechanism of altering Ca 351 to a phenolic oxygen of the covalently attached fluorescein. Because the pH sensitivity of the spectral properties of fluorescein is due to protonation or deprotonation of one of the phenolic oxygens, covalent attachment of phosphate at the same site on fluorescein would no doubt also alter its spectral properties: phosphorylation of fluorescein is already known to result in low fluorescence (54) , and 3-methylfluorescein monophosphate is a commonly used non-fluorescent but fluorogenic substrate for phosphatases as well as for Ca 2ϩ -ATPase (55). Furthermore, phosphate transfer from Asp 351 to FITC would provide an elegant explanation for our findings that high fluorescence and low fluorescence forms of FITC-ATPase have similar proteolytic patterns and cross-linking properties. Indeed, the model of fluorescein docked in the structure of E 1 ⅐ADP⅐AlF 4 Ϫ (Fig. 6A) shows that the 3-O of the xanthenolone ring can be superimposed with the terminal oxygen of the ␤-phosphate, which is in line with the ␥-phosphate analog AlF 4 Ϫ . Upon removal of Ca 2ϩ , Arg 678 might thus provide an alternative interaction for the covalently attached fluorescein monophosphate. After re-addition of Ca 2ϩ , the attached fluorescein monophosphate could act as a substrate for re-phosphorylation of Asp 351 , thus allowing Ca 2ϩ -ATPase to re-enter the catalytic cycle. There is a precedent for such a mechanism: TNP-ATP covalently attached to Lys 492 through a light-dependent azido reaction is capable of serving as a substrate upon the addition of Ca 2ϩ (56) . We investigated this possibility by analyzing tryptic digests of FITC-labeled Ca 2ϩ -ATPase prepared from control and low fluorescent phosphoenzyme preparations. The two main fluorescein-peptides were found to have indistinguishable retention times on C18 reverse-phase high performance liquid chromatography and virtually identical absorption spectra, as characterized by the optical density ratio at 210 and 495 nm (data not shown). Furthermore, the pH dependence of absorbance in 8 M urea of the covalently attached fluorescein was similar whether it was derived from control or from the low fluorescence species, which in turn was like that of FITC itself: pK a values were close to 7, and were quite different from the pK a of 4.9 for fluorescein monophosphate in solution (54) (data not shown). Based on these results, phosphate transfer from Asp 351 to the fluorescein ring does not appear to be the most likely explanation for the appearance of our low fluorescence species; rather, we attribute the low fluorescence to a unique interaction between N-and P-domains that serves to protect the aspartyl phosphate bond. However, covalent binding to Ca 2ϩ -ATPase of the putative fluorescein monophosphate could well modify its properties in unexpected ways, and the alternative hypothesis should perhaps be kept in mind.
